Celyad Oncology SA - American Depositary Shares (CYAD) analyst actions
Rating and price-target actions on CYAD in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CYAD overview →
No CYAD analyst action events in the measured window.
Nothing matched in the current window — the CYAD overview has every event we measure for this name.
Get an email when CYAD moves on news →Keep exploring
More CYAD: earnings → · SEC filings → · CYAD overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IMV Inc. - Common Shares (IMV) | 508 | -0.36% | 36% |
| CAMBREX (CBM) | 505 | 0.00% | 49% |
| DELMAR PHARMACEUTICALS (DMPI) | 504 | -0.13% | 38% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 504 | -0.09% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.